Skip to content

Boston Scientific

US · BSX #364 by market cap Listed 1970
41.98 -1.01 -2.35%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 42.76 -0.54%
After-hours 42.20 +0.52%
Overnight 42.88 -0.26%
57.6441.5841.982026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on BSX?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -35.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 2.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 17.7x Better than 49%
Forward P/E 21.3x Better than 32%
Price / Sales 3.1x Better than 41%
P/E vs own 5-yr range 5th pctl Better than 95%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 16.5% Better than 78%
Net income CAGR (3Y) 60.7% Better than 90%
Free cash flow CAGR (3Y) 55.0% Better than 86%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 69.0% Better than 82%
Operating margin 19.8% Better than 76%
Net margin 14.4% Better than 70%
Return on equity 12.6% Better than 61%
Return on invested capital 9.2% Better than 66%
Momentum D

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -16.7% Better than 36%
6-month return -27.3% Better than 20%
12-month return (ex latest month) -52.5% Better than 2%
Distance below 52-week high 58.8% Better than 11%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 45%
Debt to assets 26.2% Better than 47%
Interest coverage 10.7x Better than 74%
Free cash flow / net income 117.5% Better than 50%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 63.6% Better than 40%
Upside to average target 19.2% Better than 31%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -5.32%
1M -7.90%
3M -14.97%
6M -25.92%
YTD -55.97%
1Y -56.54%
3Y -22.92%
5Y +2.32%

Key statistics

Price & volume

Prev close
42.99
Open
42.77
Day range
41.92 - 43.23
Avg price
42.44
Volume
15.23M
Turnover
646.30M
Amplitude
3.04%
52-week range
39.57 - 101.91

Valuation

P/E
21.64
P/E (TTM)
17.71
P/B
2.37
EPS
1.94
Net profit
2.81B
Net assets
25.63B

Share structure

Market cap
60.85B
Float cap
60.67B
Shares out
1.45B

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 4% of range
39.57 101.91

58.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-346.08M net over the window

Short interest

Shares short
35.11M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Boston Scientific (BSX)?

Boston Scientific last traded at 41.98. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Boston Scientific's market cap?

About 60.85B.

What is the P/E ratio of Boston Scientific?

The trailing twelve-month P/E is 17.71, below its own 5-year average of 66.05 — toward the bottom of its historical range (5.18% percentile). See the Valuation tab for the full history.

Does Boston Scientific pay a dividend?

Boston Scientific does not currently pay a regular dividend.

Is Boston Scientific a buy according to analysts?

The consensus of 22 analysts is a Buy rating, with an average 12-month price target of 50.05, which implies 19.2% upside from the current price. This is not investment advice.

What is Boston Scientific's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Boston Scientific a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 20:02:36 · For reference only, not investment advice and not tailored to your situation.

Boston Scientific discussion 0 comments

Add a comment